SCHEMBL31527877

SCHEMBL31527877

C=C(Cc1nc(-c2ccc(Oc3ccccn3)cc2C)no1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 5/20 0.44
▸ DRD1 P21728 2/20 0.41
▸ PTGS2 P35354 1/20 0.40
▸ IP6K1 Q92551 2/20 0.39
▸ IP6K3 Q96PC2 2/20 0.39
▸ IP6K2 Q9UHH9 2/20 0.39
▸ SCN7A Q01118 5/20 0.39
▸ KCNH2 Q12809 5/20 0.39
▸ SCN5A Q14524 1/20 0.39
▸ SCN2A Q99250 1/20 0.39
▸ SCN8A Q9UQD0 1/20 0.39
▸ S1PR1 P21453 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ACACB O00763 1/20 0.38
▸ ACACA Q13085 1/20 0.38
▸ PPARG P37231 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31527956 0.89 GSTP1 (0.43) GSTP1PTGS2IP6K1IP6K3IP6K2
SCHEMBL31527931 0.89 MAPT (0.42) GSTP1PTGS2IP6K1IP6K3IP6K2
SCHEMBL30689444 0.86 SCN7A (0.38) GSTP1PTGS2IP6K1IP6K3IP6K2
SCHEMBL30689401 0.86 DRD1 (0.44) GSTP1DRD1PTGS2IP6K1IP6K3
SCHEMBL30689305 0.86 IP6K1 (0.38) GSTP1PTGS2IP6K1IP6K3IP6K2
SCHEMBL30689347 0.84 IP6K1 (0.48) GSTP1IP6K1IP6K3IP6K2TP53
SCHEMBL30689359 0.82 IP6K1 (0.39) GSTP1PTGS2IP6K1IP6K3IP6K2
SCHEMBL31528053 0.81 TSHR (0.44) GSTP1NPC1RAB9ASMN1; SMN2
SCHEMBL30689405 0.79 MAPT (0.36) GSTP1IP6K1IP6K3IP6K2TP53
SCHEMBL31527878 0.78 DRD1 (0.42) GSTP1DRD1PTGS2IP6K1IP6K3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN disclosed
Send feedback